Jam

  • DENSO and AT&T Partner to Enhance Road Safety Technology

    DENSO and AT&T are partnering to advance urban mobility with customizable services leveraging AT&T’s hardware and software. The collaboration focuses on improving road safety and optimizing driving experiences. DENSO’s MobiQ V2X OBU will support a hybrid communication model utilizing AT&T’s network and 5.9 GHz C-V2X technology. AT&T is currently testing these technologies to establish a national transportation platform, integrating localized services and city infrastructure to enhance safety and public transportation.

    2025年8月25日
  • Omai Boosts Mineral Resources: Indicated 2.1 Moz Au, Inferred 4.4 Moz Au, Driven by Wenot Deposit Expansion

    Omai Gold Mines announced a significant increase in its Mineral Resource Estimate (MRE) at the Omai Gold Property in Guyana. Indicated Mineral Resources rose 7% to 2.1 Moz Au at 2.07 g/t Au. Inferred Mineral Resources jumped 92% to 4.4 Moz Au at 1.95 g/t Au. The Wenot Deposit contains 970,000 oz gold Indicated and 3.7 Moz Inferred, while Gilt Creek holds 1.15 Moz Indicated and 665,000 oz Inferred. A drilling campaign is planned for resource expansion, targeting a Feasibility Study by late 2026. Existing infrastructure supports reduced development costs.

    2025年8月25日
  • High-Trend International Regains Nasdaq Compliance

    High-Trend International Group (HTCO) announced Nasdaq has confirmed its compliance with the minimum bid price requirement. This follows a prior notification of non-compliance in June 2025, triggered by a share price dipping below $1.00. Nasdaq granted HTCO a grace period, and the company has now maintained a share price at or above $1.00 for ten consecutive business days (August 8-21, 2025), satisfying the listing rule. The company can now concentrate on its ocean technology operations. Forward-looking statements are included, subject to risks and uncertainties detailed in company filings.

    2025年8月25日
  • XCF Global Set to Ring Nasdaq Opening Bell Today

    XCF Global (SAFX) participates in the Nasdaq Opening Bell Ceremony to mark its public listing and highlight its mission to decarbonize the aviation industry. Led by CEO Mihir Dange, XCF aims to build renewable fuel production facilities, with its New Rise Reno facility as the flagship. The ceremony will be broadcast live, showcasing XCF’s position in the sustainable aviation fuel (SAF) market. XCF is dedicated to accelerating the aviation sector’s shift to net-zero emissions through SAF development and operation.

    2025年8月25日
  • Independence Gold Provides Update on 3Ts Project Summer Exploration Program, BC

    Independence Gold (IEGCF) is advancing its 2025 exploration at the 3Ts Project in British Columbia, near Artemis Gold’s Blackwater Mine. A 16 line-km IP geophysical survey is completed, and 1,100 soil samples are collected for MMI analysis to identify gold, silver, and critical mineral anomalies. Geological mapping, rock sampling, and environmental studies are also underway. The project features at least 19 mineralized veins, with strike lengths up to 1,100m and widths up to 32m. Avison Management handles environmental monitoring.

    2025年8月25日
  • Leqembi® (lecanemab) Receives EU Approval

    Eisai, in partnership with BioArctic AB, is launching Leqembi in Europe, starting with Austria and Germany. Leqembi, approved by the European Commission in April 2025, is the first therapy targeting the underlying cause of Alzheimer’s disease (AD). Indicated for early AD patients (ApoE ε4 non-carriers or heterozygotes) with confirmed amyloid pathology, Leqembi demonstrated a 31% reduction in clinical decline in trials. Lecanemab selectively binds to aggregated soluble and insoluble forms of amyloid-beta (Aβ). It has already been approved in U.S., Japan, EU, China, etc. Common adverse reactions include infusion-related reactions and ARIA.

    2025年8月25日
  • VYVGART Demonstrates Positive Topline Results in AChR-Ab Seronegative gMG (ADAPT SERON Study)

    Argenx’s VYVGART® demonstrated statistically significant improvements in AChR-Ab seronegative generalized myasthenia gravis (gMG) patients in the ADAPT SERON phase 3 study (p=0.0068). This is the first global Phase 3 study showing benefits across MuSK+, LRP4+, and triple seronegative subtypes. Argenx plans to submit an sBLA to the FDA by the end of 2025 to expand VYVGART’s label. The drug maintained its consistent safety profile. The results position VYVGART as a potential foundational therapy for a broader gMG population.

    2025年8月25日
  • Willis Expands in Japan: Talent Boost and Specialty Focus

    Willis Towers Watson (WTW) is expanding its Corporate Risk & Broking team in Japan, hiring 22 professionals in 2025. This growth targets Japan’s projected insurance market expansion from JPY11.7 trillion in 2024 to JPY12.7 trillion by 2028. New hires strengthen Risk & Analytics, Reinsurance, Marine, Business Development, and Claims divisions, bringing expertise from firms like Marsh and Tokio Marine. Japan’s significant marine insurance market, representing 11% of the global fleet, is a key focus area.

    2025年8月24日
  • HUTCHMED Appoints Acting CEO

    HUTCHMED (HCM) CEO Dr. Weiguo Su is taking a leave of absence for health reasons. CFO Johnny Cheng has been appointed Acting CEO, retaining his CFO responsibilities. The Board assures that ongoing research, development, and commercial activities will remain on track. Dr. Su expressed confidence in the team’s ability to execute the company’s strategy. Cheng acknowledged Dr. Su’s 20 years of leadership and contributions to HUTCHMED.

    2025年8月24日
  • Golden Lake Announces Convertible Note Offering

    Golden Lake Exploration (GOLXF) secured a C$50,000 convertible note with a 10% annual interest rate, maturing on December 31, 2025. The funds will ensure its Jewel Ridge claims remain active through payments to the U.S. Bureau of Land Management. The outstanding capital can be converted into common shares at $0.05 each, subject to a four-month hold. This financing aims to maintain the mining claims but introduces potential shareholder dilution.

    2025年8月24日